The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due to a loss of traditional ...
May 14, 2026
0
5
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...
May 12, 2026
0
6
Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate ...
May 12, 2026
0
9
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
May 11, 2026
0
7
Surgery is a complicated endeavor. Even a successful surgery can lead to complications, and even the best surgeons sometimes have unsuccessful surgeries. A surgeon must rely on visual cues and their own experience to avoid ...
May 11, 2026
0
3
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies would have avoided up ...
May 8, 2026
0
18
More and more patients, instead of going straight to a doctor, first consult a chatbot about their symptoms. Artificial intelligence responds quickly, clearly, and without queues. But are its answers safe for patients?
May 6, 2026
0
2
Researchers at City of Hope and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC). ...
May 5, 2026
0
3
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study ...
May 3, 2026
0
12
Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. When tested in combination with radiation in animal models of prostate cancer, it was highly ...
Apr 29, 2026
0
11
